Cells (Mar 2022)

Adipose Triglyceride Lipase Deficiency Attenuates In Vitro Thrombus Formation without Affecting Platelet Activation and Bleeding In Vivo

  • Madeleine Goeritzer,
  • Stefanie Schlager,
  • Katharina B. Kuentzel,
  • Nemanja Vujić,
  • Melanie Korbelius,
  • Silvia Rainer,
  • Dagmar Kolb,
  • Marion Mussbacher,
  • Manuel Salzmann,
  • Waltraud C. Schrottmaier,
  • Alice Assinger,
  • Axel Schlagenhauf,
  • Corina T. Madreiter-Sokolowski,
  • Sandra Blass,
  • Thomas O. Eichmann,
  • Wolfgang F. Graier,
  • Dagmar Kratky

DOI
https://doi.org/10.3390/cells11050850
Journal volume & issue
Vol. 11, no. 5
p. 850

Abstract

Read online

According to genome-wide RNA sequencing data from human and mouse platelets, adipose triglyceride lipase (ATGL), the main lipase catalyzing triglyceride (TG) hydrolysis in cytosolic lipid droplets (LD) at neutral pH, is expressed in platelets. Currently, it is elusive to whether common lipolytic enzymes are involved in the degradation of TG in platelets. Since the consequences of ATGL deficiency in platelets are unknown, we used whole-body and platelet-specific (plat)Atgl-deficient (−/−) mice to investigate the loss of ATGL on platelet function. Our results showed that platelets accumulate only a few LD due to lack of ATGL. Stimulation with platelet-activating agonists resulted in comparable platelet activation in Atgl−/−, platAtgl−/−, and wild-type mice. Measurement of mitochondrial respiration revealed a decreased oxygen consumption rate in platelets from Atgl−/− but not from platAtgl−/− mice. Of note, global loss of ATGL was associated with an anti-thrombogenic phenotype, which was evident by reduced thrombus formation in collagen-coated channels in vitro despite unchanged bleeding and occlusion times in vivo. We conclude that genetic deletion of ATGL affects collagen-induced thrombosis without pathological bleeding and platelet activation.

Keywords